▼ SELL
$ Value
$426K
Shares
4,975
Price
$86
Filed
Aug 14
Insider
Name
Rowland Thomas Andrew
Title
SVP, HEAD - ESTABLISHED BRANDS
CIK
0001507496
Roles
Officer
Transaction Details
Transaction Date
2025-08-12
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
40,794
Footnotes
The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price. | Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).
Filing Info
Rowland Thomas Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | ANIP | ▼ | $357K |
| 2026-02-28 | ANIP | F | $46K |
| 2026-02-26 | ANIP | A | $465K |
| 2026-02-14 | ANIP | F | $38K |
| 2026-02-12 | ANIP | F | $43K |
| 2026-02-11 | ANIP | F | $134K |
| 2025-08-12 | ANIP | ▼ | $426K |
Other Insiders at ANIP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
|
— | $357K | 2026-03-11 |
|
CAREY STEPHEN P.
SVP & CFO
|
— | $552K | 2026-03-07 |
| Walsh Patrick D | — | $445K | 2026-03-03 |
|
Lalwani Nikhil
PRESIDENT & CEO
|
— | — | 2026-03-07 |
|
Gutwerg Ori
SVP, GENERICS
|
— | $158K | 2026-03-07 |
|
Mutz Christopher
HEAD OF RARE DISEASE
|
— | $1.6M | 2026-03-13 |
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
|
— | — | 2026-02-26 |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
|
— | — | 2026-02-28 |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
|
— | $114K | 2026-04-13 |
|
Davis Krista
SVP, CHIEF HR OFFICER
|
— | $785K | 2026-03-09 |